Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: The role of methadone maintenance therapy

Altice, 2004, Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication, Clin. Infect. Dis., 38, S376, 10.1086/421400

Antela, 1997, Influence of a methadone maintenance programme on the improved outcome of a cohort on injecting drug users with advanced HIV disease, AIDS, 11, 1405

Arnsten, 2002, Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users, J. Gen. Intern. Med., 17, 377, 10.1007/s11606-002-0044-3

Avants, 2004, Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy, J. Subst. Abuse Treat., 26, 67, 10.1016/S0740-5472(03)00159-4

Avants, 2001, Predictors of nonadherence to HIV-related medication regimens during methadone stabilization, Am. J. Addiction., 10, 69, 10.1080/105504901750160501

Bassetti, 1999, Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV cohort study, J. Acq. Immun. Def. Synd., 21, 114

Carpenter, 2000, Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel, JAMA, 283, 381, 10.1001/jama.283.3.381

Carrieri, 1999, Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group, J. Epidemiol. Commun. Health, 53, 4, 10.1136/jech.53.1.4

Celentano, 2001, Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users, AIDS, 15, 1707, 10.1097/00002030-200109070-00015

Conway, 2004, Directly observed therapy for the management of HIV-infected patients in a methadone program, Clin. Infect. Dis., 38, S402, 10.1086/421404

Corsi, 2002, Predictors of positive outcomes for out-of-treatment opiate injectors recruited into methadone maintenance through street outreach, J. Drug Issues, 32, 999, 10.1177/002204260203200316

Fiellin, 2001, Methadone maintenance in primary care: a randomized controlled trial, JAMA, 286, 1724, 10.1001/jama.286.14.1724

Hinkin, 2004, Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse, AIDS, 18, S19, 10.1097/00002030-200401001-00004

Hogg, 1998, Improved survival among HIV-infected individuals following initiation of antiretroviral therapy, JAMA, 279, 450, 10.1001/jama.279.6.450

Hogg, 2002, Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up, AIDS, 16, 1051, 10.1097/00002030-200205030-00012

Klinkenberg, 2004, Mental disorders and drug abuse in persons living with HIV/AIDS, AIDS Care, 16, S22, 10.1080/09540120412331315303

Liang, 1986, Longitudinal data analysis using generalized linear models, Biometrika, 73, 13, 10.1093/biomet/73.1.13

Low-Beer, 2000, Adherence to triple therapy and viral load response, J. Acq. Immune Def. Synd., 23, 360, 10.1097/00126334-200004010-00016

Lucas, 2001, Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection, J. Acq. Immune Def. Synd., 27, 251, 10.1097/00126334-200107010-00006

Lucas, 2002, Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic, AIDS, 16, 767, 10.1097/00002030-200203290-00012

Lucas, 2004, Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study, Clin. Infect. Dis., 38, S409, 10.1086/421405

Moatti, 2000, Adherence to HAART in French HIV-infected injecting drug users: the contribution of buprenorphine drug maintenance treatment. The Manif 2000 Study Group, AIDS, 14, 151, 10.1097/00002030-200001280-00010

Moore, 2004, Differences in HIV disease progression by injecting drug use in HIV-infected persons in care, J. Acq. Immune Def. Synd., 35, 46, 10.1097/00126334-200401010-00006

Moreno, 2001, Long-term outcomes of protease inhibitor-based therapy in antiretroviral treatment-naive HIV-infected injection drug users on methadone maintenance programmes, AIDS, 15, 1068, 10.1097/00002030-200105250-00021

Palella, 1998, Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators, N. Engl. J. Med., 338, 853, 10.1056/NEJM199803263381301

Palepu, 2004, Uptake and adherence to highly active antiretroviral therapy among HIV-infected people with alcohol and other substance use problems: the impact of substance abuse treatment, Addiction, 99, 361, 10.1111/j.1360-0443.2003.00670.x

Palepu, 2003, Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use, J. Acq. Immune Def. Synd., 32, 522, 10.1097/00126334-200304150-00009

Palepu, 2003, Alcohol use and incarceration adversely affect HIV-1RNA suppression among injection drug users starting antiretroviral therapy, J. Urban Health, 80, 661, 10.1093/jurban/jtg073

Palepu, 2001, Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use, AIDS, 15, 423, 10.1097/00002030-200102160-00021

Raboud, 1999, Meta-analysis of two randomized controlled trials comparing combined zidovudine and didanosine therapy with combined zidovudine, didanosine, and nevirapine therapy in patients with HIV, J. Acq. Immune Def. Synd., 22, 260, 10.1097/00126334-199911010-00007

Roca, 1999, Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: adherence, side effects and efficacy, J. Infect., 39, 141, 10.1016/S0163-4453(99)90006-3

Roca, 2000, Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients, J. Infect., 41, 50, 10.1053/jinf.2000.0678

Sambamoorthi, 2000, Drug abuse, methadone treatment, and health services use among injection drug users with AIDS, Drug Alcohol Depend., 60, 77, 10.1016/S0376-8716(99)00142-8

Soto, 2004, Literature on integrated HIV care: a review, AIDS Care, 16, S43, 10.1080/09540120412331315295

Stein, 2000, Adherence to antiretroviral therapy among HIV-infected methadone patients: Effect of ongoing illicit drug use, Am. J. Drug Alcohol Abuse, 26, 195, 10.1081/ADA-100100600

Strathdee, 1998, Barriers to use of free antiretroviral therapy in injection drug users, JAMA, 280, 547, 10.1001/jama.280.6.547

Strathdee, 1997, Needle exchange is not enough: lessons from the Vancouver injecting drug use study, AIDS, 11, F59, 10.1097/00002030-199708000-00001

Turner, 2003, Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users, J. Gen. Intern. Med., 18, 248, 10.1046/j.1525-1497.2003.20122.x

Turner, 2001, Association of provider and patient characteristics with HIV-infected women's antiretroviral therapy regimen, J. Acq. Immune Def. Synd., 27, 20, 10.1097/00126334-200105010-00004

Uldall, 2004, Adherence in people living with HIV/AIDS, mental illness, and chemical dependency: a review of the literature, AIDS Care, 16, S71, 10.1080/09540120412331315277

Wood, 2005, Impact of accessing methadone on the time to initiating HIV treatment among antiretroviral-naive HIV-infected injection drug users, AIDS, 19, 837, 10.1097/01.aids.0000168982.20456.eb

Wood, 2003, Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350×10(9) cells/L, Ann. Intern. Med., 139, 810, 10.7326/0003-4819-139-10-200311180-00008

Wood, 2004, The impact of adherence on CD4 cell count responses among HIV-infected patients, J. Acq. Immune Def. Synd., 35, 261, 10.1097/00126334-200403010-00006

Wood, 2003, Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users, Can. Med. Assoc. J., 169, 656

Wood, 2004, Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users, Antivir. Ther., 9, 229, 10.1177/135965350400900218

Yeni, 2002, Antiretroviral treatment for adult HIV infection in 2002—Updated recommendations of the international AIDS Society-USA panel, JAMA, 288, 222, 10.1001/jama.288.2.222

Yun, 2005, Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients, J. Acq. Immune Def. Synd., 38, 432, 10.1097/01.qai.0000147524.19122.fd

Zeger, 1986, Longitudinal data analysis for discrete and continuous outcomes, Biometrics, 42, 121, 10.2307/2531248

Zweben, 1990, Methadone-maintenance in the treatment of opioid dependence—a current perspective, West J. Med., 152, 588